M D Sadick

5.3k total citations · 2 hit papers
38 papers, 4.6k citations indexed

About

M D Sadick is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Molecular Biology. According to data from OpenAlex, M D Sadick has authored 38 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 12 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in M D Sadick's work include Research on Leishmaniasis Studies (16 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Trypanosoma species research and implications (5 papers). M D Sadick is often cited by papers focused on Research on Leishmaniasis Studies (16 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Trypanosoma species research and implications (5 papers). M D Sadick collaborates with scholars based in United States, Switzerland and Mali. M D Sadick's co-authors include Richard M. Locksley, Frederick P. Heinzel, B J Holaday, Robert L. Coffman, Sunita Mutha, R Pu, Thomas J. Schall, Melanie R. Mark, Jian Chen and R. Glenn Hammonds and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

M D Sadick

38 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

1989 1.3k citations Frederick P. Heinzel, M D Sadick et al. The Journal of Experimental Medicine profile →
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

1990 564 citations M D Sadick, Frederick P. Heinzel et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M D Sadick United States	25	2.3k	1.7k	1.4k	569	456	38	4.6k
Tamás Laskay Germany	37	2.5k 1.1×	2.0k 1.2×	1.4k 1.0×	837 1.5×	535 1.2×	81	5.0k
Nancy Noben-Trauth United States	28	3.7k 1.6×	1.7k 1.0×	1.1k 0.8×	650 1.1×	777 1.7×	38	5.9k
Esther von Stebut Germany	35	2.5k 1.1×	1.7k 1.0×	1.1k 0.8×	734 1.3×	311 0.7×	124	4.8k
Joseph P. Sypek United States	29	1.5k 0.6×	900 0.5×	913 0.6×	362 0.6×	387 0.8×	60	3.1k
Fabienne Tacchini‐Cottier Switzerland	42	2.4k 1.0×	2.1k 1.2×	1.3k 0.9×	808 1.4×	583 1.3×	105	4.7k
Pascale Kropf United Kingdom	33	1.9k 0.8×	1.6k 0.9×	1.4k 1.0×	632 1.1×	447 1.0×	68	4.2k
Wilhelm Schwaeble United Kingdom	53	5.8k 2.5×	910 0.5×	1.2k 0.9×	1.4k 2.4×	297 0.7×	157	8.0k
Shinjiro Hamano Japan	31	2.3k 1.0×	901 0.5×	787 0.6×	522 0.9×	790 1.7×	125	4.4k
Maria Wysocka United States	36	5.6k 2.4×	893 0.5×	2.1k 1.5×	1.3k 2.2×	1.1k 2.4×	59	8.7k
Damo Xu United Kingdom	28	3.9k 1.7×	778 0.5×	977 0.7×	1.1k 2.0×	300 0.7×	35	6.0k

Countries citing papers authored by M D Sadick

Since Specialization

Citations

This map shows the geographic impact of M D Sadick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M D Sadick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M D Sadick more than expected).

Fields of papers citing papers by M D Sadick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M D Sadick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M D Sadick. The network helps show where M D Sadick may publish in the future.

Co-authorship network of co-authors of M D Sadick

This figure shows the co-authorship network connecting the top 25 collaborators of M D Sadick. A scholar is included among the top collaborators of M D Sadick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M D Sadick. M D Sadick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sadick, M D. (2002). Understanding the puzzle of ‘well-characterized biotechnology products’. Current Opinion in Biotechnology. 13(3). 275–278. 3 indexed citations

Hongo, Jo-Anne, Gary R. Laramee, Roman Urfer, et al.. (2000). Antibody Binding Regions on Human Nerve Growth Factor Identified by Homolog- and Alanine-Scanning Mutagenesis. Hybridoma. 19(3). 215–227. 28 indexed citations

Nakamura, Morio, Seitaro Fujishima, Makoto Sawafuji, et al.. (2000). Importance of Interleukin-8 in the Development of Reexpansion Lung Injury in Rabbits. American Journal of Respiratory and Critical Care Medicine. 161(3). 1030–1036. 65 indexed citations

Szönyi, Éva, et al.. (2000). Stability and Interactions of Recombinant Human Nerve Growth Factor in Different Biological Matrices: In Vitro and In Vivo Studies. Drug Metabolism and Disposition. 28(5). 590–597. 10 indexed citations

Sadick, M D, et al.. (1999). Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays. Journal of Pharmaceutical and Biomedical Analysis. 19(6). 883–891. 50 indexed citations

Sadick, M D, et al.. (1997). Analysis of Neurotrophin/Receptor Interactions with a gD-Flag-Modified Quantitative Kinase Receptor Activation (gD.KIRA) Enzyme-Linked Immunosorbent Assay. Experimental Cell Research. 234(2). 354–361. 22 indexed citations

Sadick, M D, Mark X. Sliwkowski, Andrew Nuijens, et al.. (1996). Analysis of Heregulin-Induced ErbB2 Phosphorylation with a High-Throughput Kinase Receptor Activation Enzyme-Linked Immunosorbant Assay. Analytical Biochemistry. 235(2). 207–214. 21 indexed citations

Godowski, Paul J., Melanie R. Mark, Jian Chen, et al.. (1995). Reevaluation of the roles of protein S and gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell. 82(3). 355–358. 186 indexed citations

Devergne, Odile, Anne Marfaing‐Koka, Thomas J. Schall, et al.. (1994). Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells.. The Journal of Experimental Medicine. 179(5). 1689–1694. 194 indexed citations

10.

Petraglia, Felice, Pasquale Florio, M D Sadick, et al.. (1993). Activin A and activin B measured in maternal serum, cord blood serum andamniotic fluid during human pregnancy. Endocrine Journal. 1. 323–327. 47 indexed citations

11.

Woodruff, Teresa K., et al.. (1993). Inhibin and activin measured in human serum.. Human Reproduction. 7 indexed citations

12.

Woodruff, Teresa K., Lynne Krummen, D L Baly, et al.. (1993). Quantitative two-site enzyme-linked immunosorbent assays for inhibin A, activin A and activin B. Human Reproduction. 8(suppl 2). 133–137. 13 indexed citations

13.

Rathanaswami, Palaniswami, M. Hachicha, M D Sadick, Thomas J. Schall, & Shaun R. McColl. (1993). Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines.. Journal of Biological Chemistry. 268(8). 5834–5839. 263 indexed citations

14.

Locksley, Richard M., et al.. (1991). Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. Research in Immunology. 142(1). 28–32. 91 indexed citations

15.

Holaday, B J, M D Sadick, Steven L. Reiner, et al.. (1991). Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. The Journal of Immunology. 147(5). 1653–1658. 124 indexed citations

16.

Sadick, M D, et al.. (1990). Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.. The Journal of Experimental Medicine. 171(1). 115–127. 564 indexed citations breakdown →

17.

Heinzel, Frederick P., M D Sadick, B J Holaday, Robert L. Coffman, & Richard M. Locksley. (1989). Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.. The Journal of Experimental Medicine. 169(1). 59–72. 1254 indexed citations breakdown →

18.

Heinzel, Frederick P., M D Sadick, & Richard M. Locksley. (1988). Leishmania major: Analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice. Experimental Parasitology. 65(2). 258–268. 20 indexed citations

19.

Locksley, Richard M., Suzanne M. Crowe, M D Sadick, et al.. (1988). Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.. Journal of Clinical Investigation. 82(6). 2097–2105. 48 indexed citations

20.

Sadick, M D, et al.. (1987). Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.. The Journal of Immunology. 139(4). 1303–1309. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact